Rakovina Therapeutics Announces Final Closing of Upsized Non-Brokered Private Placement

Financing completed at the full upsized amount following strong investor demand VANCOUVER, British Columbia, Aug. 31, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is pleased to announce that it has closed the second and final tranche (the “Second Tranche”) of […]